News

January 5, 2017

essentialis-and-capnia-announce-merger-to-create-rare-disease-therapeutics-company

September 23, 2015

Essentialis Presents Results From Clinical Study PC025 Evaluating DCCR in the Treatment of Prader Willi Syndrome at FPWR 2015 Annual Meeting

September 8, 2015

Essentialis Announces the Dosing of the First Prader-Willi Syndrome Patients in a Long-Term Extension to Clinical Trial PC025

July 20, 2015

Essentialis Presents Corporate Update at Cantor Fitzgerald Inaugural Healthcare Conference

March 26, 2015

Essentialis Presents Results From the First Phase of Clinical Study PC025 Evaluating DCCR in the Treatment of Prader Willi Syndrome at ACMG Annual Clinical Genetic Meeting